The relationship between the efficacy of thermal ablation and inflammatory response and immune status in early hepatocellular carcinoma and the progress of postoperative adjuvant therapy

Chen, Shuanggang; Shen, Binyan; Wu, Ying; Shen, Lujun; Qi, Han; Cao, Fei; Huang, Tao; Tan, Hongtong; Wen, Chunyong; Fan, Weijun

doi:10.1016/j.intimp.2023.110228

Cited by 1 publication

(1 citation statement)

References 80 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, it can trigger extracellular matrix development via the transformation of growth factor-beta, resulting in unfavorable outcomes for individuals diagnosed with HCC. 18 , 19 Prealbumin has been reported to indicate the body’s acute inflammatory state and has the potential to be a prognostic biomarker for tumors. 20 Although the exact effect of prealbumin on the prognosis of individuals with HCC is not completely known, it is widely accepted that the tumor microenvironment promotes tumor development, progression, invasion, and metastasis by causing immune suppression, ultimately affecting patient prognosis.…”

Section: Discussionmentioning

confidence: 99%

Development and Validation of a Prognostic Model for Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma Based on Preoperative Serum Prealbumin

Xu,

Zhao,

Tian

et al. 2023

JHC

View full text Add to dashboard Cite

Purpose We aimed to develop a prognostic nomogram utilizing preoperative serum prealbumin levels to predict the overall survival (OS) in patients undergoing transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC). Patients and Methods A total of 768 individuals with unresectable HCC who underwent TACE at three medical facilities in Suzhou between January 2007 December 2018 were included. The patient cohort was assigned to a training set (n = 461) and a validation set (n = 307). Cox regression analysis identified independent prognostic factors, which were then used to construct a prognostic nomogram. Internal validation was performed in the testing group, and its effectiveness and capability were evaluated with reference to the concordance index (C-index), area under the curve (AUC), calibration curve, and decision curve analysis (DCA). Results Independent risk factors identified through Cox regression analyses included the BCLC stage, cirrhosis, invasion, tumor number, preoperative serum PALB, performance status (PS), and tumor size. The nomogram demonstrated a C-index of 0.734 (95% confidence interval (CI): 0.710–0.758) in the training set and 0.717 (95% CI: 0.678–0.756) in the validation set, indicating strong discriminatory ability. The nomogram also demonstrated favorable discriminatory performance with AUC values of 0.873, 0.820, and 0.833 for 1-, 2-, and 3-year OS, respectively, in the training set, and 0.854, 0.765, and 0.724 in the validation set. The AUC value of the nomogram (0.843) was significantly higher than that of the four conventional staging systems. Moreover, calibration graphs confirmed a strong concordance between the predicted and observed results. Furthermore, DCA underscored the significant clinical utility of the nomogram. Additionally, the low-risk group exhibited considerably superior rates of survival compared to the high-risk group. Conclusion The developed nomogram demonstrated excellent prognostic capability, which served as a valuable tool for personalized clinical decision-making for patients with HCC.

show abstract

Section: Discussionmentioning

confidence: 99%